API Gefitinib CAS 184475-35-2

Deskripsyon kout:

Gefitinib yo itilize pou trete kansè nan poumon ki pa ti selil ki gaye nan lòt pati nan kò a nan moun ki gen sèten kalite timè.Gefitinib se nan yon klas nan medikaman yo rele inibitè kinaz.Li travay pa bloke aksyon an nan yon sèten sibstans ki rive natirèlman ki ka bezwen ede selil kansè yo miltipliye.

Kontakte: Erica Zheng

Email: erica@zhuoerchem.com

Tel: +86 21 2097 0332

Mob: +86 177 1767 9251

WhatsApp: +86 186 2503 6043 (WeChat & Telegram & Liy)

Skype: slhyzy

Voye imèl ba nou

Pwodwi detay

Tags pwodwi

Deskripsyon

Gefitinib yo itilize pou trete kansè nan poumon.

Spesifikasyon:

Non pwodwi	Gefitinib
Non Chimik	N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine Gefitinib
Lòt Non	N-(3-Chlor-4-fluorophenyl)-7-[methoxy-6-[(3-morpholin-4-yl)propoxyl]-quinazolin-4-yl]amine;GEFITINIBRELATEDCOMPOUND;GefitinibN-(3-Chloro-4 -fluoro-phenyl)-7Chemicalbook-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;IRESSA;GEFITINIB;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6 -(3-morpholin-4-ylpropoxy)quinazolin-4-amine
Nimewo CAS	184475-35-2
Fòmil molekilè	C22H24ClFN4O3
Pwa fòmil	446.9
Aparans	Poud blan
Esè	99.0% min
Pwen k ap fonn	119-120 °C
Pwen bouyi	586.8±50.0 °C
Dansite	1.322±0.06 g/cm3
Pake	20kg / sak / tanbou, 25kg / sak / tanbou, oswa jan ou mande yo
Depo	Sere veso a byen fèmen nan yon kote ki sèk ak fre.Pa ekspoze a limyè solèy la dirèk.
COA & MSDS	Disponib
Aplikasyon	Pou rezon rechèch